Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets

Milioli, HH; Alexandrou, S; Lim, E; Caldon, CE

Caldon, CE (corresponding author), Garvan Inst Med Res, Sydney, NSW, Australia.; Caldon, CE (corresponding author), UNSW Sydney, St Vincents Clin Sch, Sydney, NSW, Australia.

ENDOCRINE-RELATED CANCER, 2020; 27 (5): R93

Abstract

Cyclin E1 is one the most promising biomarkers in estrogen receptor positive (ER+) breast cancer for response to the new standard of care drug class, ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索